Transgene SA
TRGNF
$0.70
-$0.89-55.98%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | 7.85% | 52.66% | |||
| Total Revenue | 7.85% | 50.88% | |||
| Cost of Revenue | 7.85% | -6.23% | |||
| Gross Profit | -7.85% | 17.01% | |||
| SG&A Expenses | 7.85% | 16.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -7.75% | -154.41% | |||
| Total Operating Expenses | 7.85% | -3.58% | |||
| Operating Income | -7.85% | 12.10% | |||
| Income Before Tax | -7.85% | -8.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.85% | -8.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.85% | -8.93% | |||
| EBIT | -7.85% | 12.10% | |||
| EBITDA | -7.85% | 11.17% | |||
| EPS Basic | -7.83% | -8.81% | |||
| Normalized Basic EPS | -7.72% | -8.86% | |||
| EPS Diluted | -7.86% | -10.81% | |||
| Normalized Diluted EPS | -7.72% | -8.86% | |||
| Average Basic Shares Outstanding | 0.00% | 0.10% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||